Table 1 Patients’ characteristics
From: Assessment of a new point-of-care system for detection of prostate specific antigen
Median patient age, years (Range) | 66.15 | (42.06–90.09) | |
|---|---|---|---|
Patient groups according to Immulite® measurement | n= | % | |
≤4 ng/ml | 131 | 65.8 % | |
>4 ng/ml | 67 | 34.2 % | |
≤10 ng/ml | 168 | 84.8 % | |
>10 ng/ml | 30 | 15.2 % | |
Further diagnostic workup | |||
Histology availablea | Yes | 69 | 34.7 % |
No | 130 | 65.3 % | |
Histologic evidence of prostate cancer | Yes | 36 | 52.2 % |
No | 30 | 43.5 % | |
Median | 95 % CI | ||
PSA values | Immulite® | 2.34 | 2.07 to 3.10 |
Centaur® | 1.90 | 1.70 to 2.33 | |
concile® | 2.53 | 2.10 to 3.15 | |